Fish Farmer

Fürst Medical Laboratory swoops for Patogen


FISH health company PatoGen has been acquired by Norway’s Fürst Medical Laboratory, which has promised to continue developing the business.

PatoGen is a leading provider of preventive and diagnostic analysis for the aquacultur­e industry in Norway and Scotland. It has operations in Norway – in Ålesund, Oslo and Bodø – and Oban in Scotland. In total, PatoGen has nearly 60 employees and its revenue in 2020 was just under NOK 100m (£8m).

Fürst, which is the largest medical laboratory in Norway, has acquired 100% of PatoGen’s shares.The deal brings it into the aquacultur­e market for the first time – its core business is providing analytical services to the healthcare sector.

The CEO of Fürst, Håvard

Selby Ebbestad, said: “Fürst has a long lasting and solid experience running effective laboratori­es and diagnostic­s. Becoming owners of PatoGen, we also get exposure to preventive and diagnostic analyses in fish.This is an attractive market for us, and we are confident we can make a valuable contributi­on to the aquacultur­e companies to improve their fish health and fish welfare.”

 ??  ??

Newspapers in English

Newspapers from United Kingdom